Dana-Farber’s Breast Oncology Center shared a post on X:
“This new study examines integrative multi-omic profiling of Triple Negative Breast Cancer for identifying suitable therapies. Rachel Freedman are leading efforts to improve access to clinical trials and to ensure that research reflects all communities.”
Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies
Authors: Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel.
